Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Boston Scientific Corp (BSX)  
$72.91 3.92 (5.68%) as of 4:30 Wed 4/24


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 1,430,000,000
Market Cap: 104.26(B)
Last Volume: 15,276,394 Avg Vol: 8,465,245
52 Week Range: $48.64 - $68.84
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  297
Guru Rank Value     : 4.1
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 86,763 367,796 891,893 1,852,495
Total Sell Value $5,815,387 $21,391,604 $49,075,093 $90,475,166
Total People Sold 6 8 11 13
Total Sell Transactions 9 19 36 69
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 1825
  Page 8 of 73  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Brennan Daniel J. EVP and CFOOfficer   •       –      –    2014-01-01 3 IO $0.00 $0 D/D 0 68,487     -
   Mario Ernest Director   •       •      –    2013-12-26 4 AS $12.06 $120,600 D/D (10,000) 384,959     -
   Nicholas Nicholas J Jr Director   •       •      –    2013-11-27 4 GD $0.00 $0 I/I 15,000 22,000     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       •      –    2013-11-27 4 S $11.70 $1,270,583 D/D (108,595) 447     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       •      –    2013-11-26 4 S $11.82 $1,005,698 D/D (85,106) 109,042     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       •      –    2013-11-26 4 OE $6.28 $296,129 D/D 46,701 194,148     -
   Ballinger Kevin J. SVP & Pres, Interven Cardio   •       •      –    2013-11-25 4 S $12.05 $401,675 D/D (33,334) 45,147     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       •      –    2013-11-25 4 S $12.02 $2,915,068 D/D (242,504) 147,447     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       •      –    2013-11-25 4 OE $6.91 $1,780,911 D/D 242,504 389,951     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       •      –    2013-11-22 4 S $12.02 $1,803,090 D/D (150,000) 147,447     -
   Capello Jeffrey D EVP & Chief Financial Officer   •       •      –    2013-11-22 4 OE $7.41 $1,217,468 D/D 150,000 297,447     -
   Dawkins Keith D EVP, Global Chief Med. Off.   •       •      –    2013-11-21 4 S $12.00 $1,666,339 D/D (138,850) 81,802     -
   Dawkins Keith D EVP, Global Chief Med. Off.   •       •      –    2013-11-21 4 OE $7.16 $1,039,152 D/D 138,850 220,652     -
   Nicholas Nicholas J Jr Director   •       •      –    2013-11-20 4 GD $0.00 $0 I/I 2,000 8,000     -
   Nicholas Nicholas J Jr Director   •       •      –    2013-11-20 4 GA $0.00 $0 I/I 2,000 37,000     -
   Pratt Timothy A. EVP, GC & Chief Admin Officer   •       •      –    2013-11-19 4 S $11.94 $240,376 D/D (20,132) 119,011     -
   Mirviss Jeffrey B. SVP&Pres, Periph Intervent   •       •      –    2013-11-11 4/A S $12.02 $72,128 D/D (6,000) 59,190     -
   Mirviss Jeffrey B. SVP&Pres, Periph Intervent   •       •      –    2013-11-11 4 S $12.02 $72,128 D/D (6,000) 39,190     -
   Mirviss Jeffrey B. SVP&Pres, Periph Intervent   •       •      –    2013-11-08 4/A S $11.87 $237,402 D/D (20,000) 65,190     -
   Mirviss Jeffrey B. SVP&Pres, Periph Intervent   •       •      –    2013-11-08 4/A OE $6.31 $126,200 D/D 20,000 85,190     -
   Mario Ernest Director   •       •      –    2013-11-08 4 S $11.73 $239,857 I/I (20,445) 0     -
   Mario Ernest Director   •       •      –    2013-11-08 4 S $11.73 $1,351,503 D/D (115,200) 394,959     -
   Mirviss Jeffrey B. SVP&Pres, Periph Intervent   •       •      –    2013-11-08 4 S $11.87 $237,402 D/D (20,000) 45,190     -
   Mahoney Michael F President & CEO   •       •      –    2013-11-01 4 D $11.75 $1,894,899 D/D (161,268) 474,430     -
   Mahoney Michael F President & CEO   •       •      –    2013-11-01 4 OE $0.00 $0 D/D 341,669 635,698     -
  1825 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 73
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us